Bone marrow mesenchymal stem cells improve spinal function of spinal cord injury in rats via TGF-β/Smads signaling pathway

Lv,Chaoliang; Zhang,Tao; Li,Kang; Gao,Kai

doi:10.3892/etm.2020.8640

Bone marrow mesenchymal stem cells improve spinal function of spinal cord injury in rats via TGF-β/Smads signaling pathway

Authors:
- Chaoliang Lv
- Tao Zhang
- Kang Li
- Kai Gao
View Affiliations

Affiliations: Department of Spine Surgery, Jining No. 1 People's Hospital, Affiliated Jining No. 1 People's Hospital of Jining Medical University, Jining Medical University, Jining, Shandong 272011, P.R. China
Published online on: April 2, 2020 https://doi.org/10.3892/etm.2020.8640
Pages: 3657-3663
Copyright: © Lv et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone marrow mesenchymal stem cells (BMSCs) on the repair of spinal cord injury (SCI) in rats as well as the role of transforming growth factor‑β (TGF-β)/Smads signaling pathway in the repair were investigated. Rat BMSCs and astrocyte-spinal cords (ASCs) were isolated and cultured in vitro, and the cell purity was detected by flow cytometry. ASCs were co-cultured with TGF-β1, BMSCs and BMSCs + TGF‑β1, respectively, and grouped accordingly, and ASCs cultured conventionally were included into control group. 3-(4,5)-Dimethylthiahiazo(-z-y1)-3,5‑diphenyltetrazoliumbromide (MTT) assay was conducted to detect the proliferation ability of ASCs in each group. Western blotting (WB) was utilized to examine the expression of TGF‑β/Smads signaling pathway‑related proteins [TGF‑β1, Smad2 and phosphorylated (p)‑Smad2] in ASCs and ASCs co‑cultured with BMSCs. A rat model of SCI was established, and BMSCs were injected locally. Then (BBB) score was used to evaluate spinal cord repair, and WB was adopted to detect the expression of TGF‑β1, Smad2 and p‑Smad2 at the injured site. BMSCs and ASCs isolated in vitro grew well. According to MTT assay results, TGF‑β1 significantly promoted the proliferation of ASCs (P<0.05), and co‑culture of ASCs and BMSCs remarkably reduced the proliferation of ASCs (P<0.05). The detection of protein expression at the SCI site via WB demonstrated that the expression of TGF‑β1, Smad2 and p‑Smad2 in SCI group were obviously upregulated compared with those in Sham group at 1 week (P<0.05), and the injection of BMSCs could markedly downregulate the expression (P<0.05). After 3 week, there were no significant differences in the expression of TGF‑β1, Smad2 and p‑Smad2 among groups (P>0.05). The transplantation of BMSCs can improve the spinal function of SCI rats probably by inhibiting the TGF‑β/Smads signaling pathway and reducing the proliferation of ASCs.

View Figures

View References

1	Himes BT, Neuhuber B, Coleman C, Kushner R, Swanger SA, Kopen GC, Wagner J, Shumsky JS and Fischer I: Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair. 20:278–296. 2006.PubMed/NCBI View Article : Google Scholar
2	Li JW, Kuang Y, Chen L and Wang JF: LncRNA ZNF667-AS1 inhibits inflammatory response and promotes recovery of spinal cord injury via suppressing JAK-STAT pathway. Eur Rev Med Pharmacol Sci. 22:7614–7620. 2018.PubMed/NCBI View Article : Google Scholar
3	Priebe MM, Chiodo AE, Scelza WM, Kirshblum SC, Wuermser LA and Ho CH: Spinal cord injury medicine. Economic and societal issues in spinal cord injury. Arch Phys Med Rehabil. 88 (Suppl 1):S84–S88. 2007.PubMed/NCBI View Article : Google Scholar
4	Chhabra HS and Arora M: Demographic profile of traumatic spinal cord injuries admitted at Indian Spinal Injuries Centre with special emphasis on mode of injury: A retrospective study. Spinal Cord. 50:745–754. 2012.PubMed/NCBI View Article : Google Scholar
5	Karimi-Abdolrezaee S and Billakanti R: Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol Neurobiol. 46:251–264. 2012.PubMed/NCBI View Article : Google Scholar
6	Fitch MT and Silver J: Glial cell extracellular matrix: Boundaries for axon growth in development and regeneration. Cell Tissue Res. 290:379–384. 1997.PubMed/NCBI View Article : Google Scholar
7	Fitch MT and Silver J: CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol. 209:294–301. 2008.PubMed/NCBI View Article : Google Scholar
8	Sofroniew MV and Vinters HV: Astrocytes: Biology and pathology. Acta Neuropathol. 119:7–35. 2010.PubMed/NCBI View Article : Google Scholar
9	Sofroniew MV: Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32:638–647. 2009.PubMed/NCBI View Article : Google Scholar
10	Silver J and Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci. 5:146–156. 2004.PubMed/NCBI View Article : Google Scholar
11	Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S and Sofroniew MV: STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci. 28:7231–7243. 2008.PubMed/NCBI View Article : Google Scholar
12	Ji M, Bai C, Li L, Fan Y, Ma C, Li X and Guan W: Biological characterization of sheep kidney-derived mesenchymal stem cells. Exp Ther Med. 12:3963–3971. 2016.PubMed/NCBI View Article : Google Scholar
13	Lin GL, Wang H, Dai J, Li X, Guan M, Ding Q, Wang HX and Fang H: Upregulation of UBAP2L in bone marrow mesenchymal stem cells promotes functional recovery in rats with spinal cord injury. Curr Med Sci. 38:1081–1089. 2018.PubMed/NCBI View Article : Google Scholar
14	Syková E, Jendelová P, Urdzíková L, Lesný P and Hejcl A: Bone marrow stem cells and polymer hydrogel - two strategies for spinal cord injury repair. Cell Mol Neurobiol. 26:1113–1129. 2006.PubMed/NCBI View Article : Google Scholar
15	Ankeny DP, McTigue DM and Jakeman LB: Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol. 190:17–31. 2004.PubMed/NCBI View Article : Google Scholar
16	Namjoo Z, Mortezaee K, Joghataei MT, Moradi F, Piryaei A, Abbasi Y, Hosseini A and Majidpoor J: Targeting axonal degeneration and demyelination using combination administration of 17β-estradiol and Schwann cells in the rat model of spinal cord injury. J Cell Biochem. 119:10195–10203. 2018.PubMed/NCBI View Article : Google Scholar
17	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995.PubMed/NCBI View Article : Google Scholar
18	McKeon RJ, Jurynec MJ and Buck CR: The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci. 19:10778–10788. 1999.PubMed/NCBI
19	Yu Z, Yu P, Chen H and Geller HM: Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway. J Neurochem. 130:41–49. 2014.PubMed/NCBI View Article : Google Scholar
20	Leask A and Abraham DJ: TGF-beta signaling and the fibrotic response. FASEB J. 18:816–827. 2004.PubMed/NCBI View Article : Google Scholar
21	Hausmann ON: Post-traumatic inflammation following spinal cord injury. Spinal Cord. 41:369–378. 2003.PubMed/NCBI View Article : Google Scholar
22	Wang H, Katagiri Y, McCann TE, Unsworth E, Goldsmith P, Yu ZX, Tan F, Santiago L, Mills EM, Wang Y, et al: Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J Cell Sci. 121:3083–3091. 2008.PubMed/NCBI View Article : Google Scholar
23	Schönherr E, Järveläinen HT, Sandell LJ and Wight TN: Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 266:17640–17647. 1991.PubMed/NCBI
24	Heimer R, Bashey RI, Kyle J and Jimenez SA: TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J Mol Cell Cardiol. 27:2191–2198. 1995.PubMed/NCBI View Article : Google Scholar
25	Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M and Longaker MT: Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg. 108:423–429. 2001.PubMed/NCBI View Article : Google Scholar
26	O’Brien MF, Lenke LG, Lou J, Bridwell KH and Joyce ME: Astrocyte response and transforming growth factor-beta localization in acute spinal cord injury. Spine. 19:2321–2330. 1994.PubMed/NCBI View Article : Google Scholar
27	Ohta M, Suzuki Y, Noda T, Ejiri Y, Dezawa M, Kataoka K, Chou H, Ishikawa N, Matsumoto N, Iwashita Y, et al: Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol. 187:266–278. 2004.PubMed/NCBI View Article : Google Scholar
28	Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G and Fischer I: Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res. 1035:73–85. 2005.PubMed/NCBI View Article : Google Scholar
29	Dai G, Liu X, Zhang Z, Yang Z, Dai Y and Xu R: Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury. Brain Res. 1533:73–79. 2013.PubMed/NCBI View Article : Google Scholar